PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Neuro-Oncology Pediatrics0 citationsOpen Access

Data-Driven In Silico Avatar Models for Pediatric DMG Clinical Management

DMG-32. Data-driven in silico avatar models of DMG for guiding clinical patient management

View Full Paper
Ask AI
Bookmark
Share

Authors

HJHui Jeong JungBKBettina KritzerSLSandra Laternser

Discussion

Loading...

Member takes

Overview

AI-based drug response predictions improve outcomes in diffuse midline glioma, suggesting data-driven treatment approaches.

Key Points

  • This research aims to develop in silico models that predict drug responses for diffuse midline glioma in pediatric patients.
  • Utilized AI-based predictions and drug screening on DMG cells and patient specimens.
  • Generated bulk RNA and whole genome data from pediatric brain cancer cell lines.
  • Applied deep learning and graph neural networks to analyze drug-response data.
  • Performed longitudinal Live-cell imaging to assess drug efficacy over 14 days.
  • Achieved a Pearson correlation of 0.66 in drug response predictions using Random Forest regression.
  • Demonstrated high fidelity of DMG cell lines reflecting patient molecular profiles.
  • Identified disparities in drug-induced cell death and proliferation patterns, emphasizing the need for longitudinal monitoring.

Cite This Study

Jung et al. (2025) studied this question.

synapsesocial.com/papers/69b4adb518185d8a398017behttps://doi.org/10.1093/neuped/wuaf001.062
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1DMG-37. Transcriptomics-based AI drug discovery in diffuse midline glioma2025
  2. 2DDDR-27. Transcriptomics-based AI drug discovery in diffuse midline glioma2025
  3. 3ID #992 Trajectory-Aware Functional Drug Screening Bridges Preclinical and Clinical Response Metrics in Diffuse Midline Glioma2026
  4. 4Abstract 1822 Deciphering the Proteomic Landscape: Understanding the Tumor Microenvironment in Diffuse Midline Glioma2024
  5. 5DIPG-66. MULTIPLEXED IMMUNOFLUORESCENCE MAPPING AND AI MODEL PREDICTION OF TUMOR MICROENVIRONMENT IN DIFFUSE MIDLINE GLIOMAS2024